Conditions: Anemia
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 513
Healthy volunteers: no

Brief summary:
The Objective of this study is to study the safety of FCM in patients with anemia caused by chronic kidney failure

Detailed description:

Arms:
arm 1: Subjects received an undiluted dose of iron as FCM IV (15 mg/kg up to a maximum of 1000 mg) or subjects received 200 mg of FCM IV push undiluted directly into the venous line of the dialyzer. arm 2: SMC for IDA (as determined by the Investigator) for treating CKD related anemia.

Interventions: intervention 1: Ferric Carboxymaltose intervention 2: Standard Medical Care (SMC)
Intervention descriptions: intervention 1: None intervention 2: None

Protocol document: